179 related articles for article (PubMed ID: 6205601)
1. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms.
Lloyd RV; Mervak T; Schmidt K; Warner TF; Wilson BS
Am J Surg Pathol; 1984 Aug; 8(8):607-14. PubMed ID: 6205601
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Andrews GA; Myers NC; Chard-Bergstrom C
Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
4. Synaptophysin. A new marker for pancreatic neuroendocrine tumors.
Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE
Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010
[TBL] [Abstract][Full Text] [Related]
5. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
6. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors.
Lloyd RV; Cano M; Rosa P; Hille A; Huttner WB
Am J Pathol; 1988 Feb; 130(2):296-304. PubMed ID: 3341449
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast.
Bussolati G; Gugliotta P; Sapino A; Eusebi V; Lloyd RV
Am J Pathol; 1985 Aug; 120(2):186-92. PubMed ID: 4025508
[TBL] [Abstract][Full Text] [Related]
8. Localization of chromogranin A-immunoreactivity in bovine gastrointestinal endocrine cells with special reference to Grimelius silver stain.
Kawakita S; Takatsuki K; Tsukada M; Yoneda M; Takano T; Kawakubo A; Nagura H
Endocrinol Jpn; 1990 Apr; 37(2):299-308. PubMed ID: 1699753
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y
Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors.
Yantiss RK; Chang HK; Farraye FA; Compton CC; Odze RD
Am J Surg Pathol; 2002 Jul; 26(7):893-901. PubMed ID: 12131156
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV
Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A immunoreactivity and Grimelius' argyrophilia. A correlative study in mammalian endocrine cells.
Cetin Y
Anat Embryol (Berl); 1992; 185(3):207-15. PubMed ID: 1349463
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase.
Seshi B; True L; Carter D; Rosai J
Am J Pathol; 1988 May; 131(2):258-69. PubMed ID: 3282444
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors.
Tomita T
Islets; 2011; 3(6):344-51. PubMed ID: 21983096
[TBL] [Abstract][Full Text] [Related]
15. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin in endocrine pancreatic tumors.
Jacobsson B; Carlström A; Collins VP; Grimelius L
Am J Pathol; 1989 Feb; 134(2):465-71. PubMed ID: 2464944
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
Bordi C; Pilato FP; D'Adda T
Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642
[TBL] [Abstract][Full Text] [Related]
18. Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors.
Marsh WL; Colonna J; Yearsley M; Bloomston M; Frankel WL
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):216-9. PubMed ID: 19391217
[TBL] [Abstract][Full Text] [Related]
19. A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Endocrinol (Copenh); 1990 Feb; 122(2):145-55. PubMed ID: 2316306
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
